Generic Threat To Amarin's Vascepa Overrides Positive Sentiment On Coronavirus Announcement
Amarin Corporation plc (NASDAQ: AMRN) shares, which were higher in after-hours trading Thursday following the company's announcement regarding a third-party pilot trial of its Vascepa in COVID-19, were giving back the gains Friday.
